190 related articles for article (PubMed ID: 5791000)
1. Alkylating agents in bronchogenic carcinoma.
Green RA; Humphrey E; Close H; Patno ME
Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
[No Abstract] [Full Text] [Related]
2. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
Tate CF; Viamonte M; Agnew JR
Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
[No Abstract] [Full Text] [Related]
3. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
[No Abstract] [Full Text] [Related]
4. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide in disseminated bronchial carcinoma.
Cameron SJ; Grant IW; Crompton GK
Scott Med J; 1974 Mar; 19(2):81-6. PubMed ID: 4365318
[No Abstract] [Full Text] [Related]
6. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
7. Bronchogenic carcinoma: nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project.
Slack NH
Cancer; 1970 May; 25(5):987-1002. PubMed ID: 4315360
[No Abstract] [Full Text] [Related]
8. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
9. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
10. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
Shepard KV; Golomb HM; Bitran JD; Hoffman PC; Newman SB; DeMeester TR; Skosey C
Cancer; 1985 Nov; 56(10):2385-90. PubMed ID: 3876149
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
Olshin S; Siddiqui S; Firat D
Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
[No Abstract] [Full Text] [Related]
12. [Place of chemotherapy in the treatment of primary bronchial cancers].
Clément F
Bronches; 1972; 22(3):176-89. PubMed ID: 4349927
[No Abstract] [Full Text] [Related]
13. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Hutcheon AW; Palmer JB; Pratt MA; Clark RA
Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
[No Abstract] [Full Text] [Related]
14. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
15. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
Young RC; DeVita VT; Serpick AA; Canellos GP
N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
17. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
19. Split-course irradiation compared to split-course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma--a randomized study of 53 patients.
Landgren RC; Hussey DH; Barkley HT; Samuels ML
Cancer; 1974 Nov; 34(5):1598-601. PubMed ID: 4426027
[No Abstract] [Full Text] [Related]
20. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
